Table 1 Baseline patient characteristics of patients with and without gastric cancer
Demographic data | Patients with gastric cancer n = 28,753 | Matched cohort n = 28,753 | P value | ||
|---|---|---|---|---|---|
n | % | n | % | ||
Age (years) (interquartile range) | 69 (55–77) | 69 (55–77) | |||
≥65 | 16,889 | 58.7 | 16,889 | 58.7 | 1.000 |
< 65 | 11,864 | 41.3 | 11,864 | 41.3 | . |
Sex | |||||
Male | 19,464 | 67.7 | 19,464 | 67.7 | 1.000 |
Female | 9289 | 32.3 | 9289 | 32.3 | . |
Comorbidities | |||||
Diabetes mellitus | 7895 | 27.5 | 7894 | 27.5 | 0.993 |
Hypertension | 14,302 | 49.7 | 14,304 | 49.7 | 0.987 |
Heart failure | 3712 | 12.9 | 3711 | 12.9 | 0.990 |
COPD | 8586 | 29.9 | 8584 | 29.9 | 0.985 |
Chronic kidney disease | 4123 | 14.3 | 4122 | 14.3 | 0.991 |
Cirrhosis | 1469 | 5.1 | 1420 | 4.9 | 0.350 |
Autoimmune diseases | 1721 | 6 | 1719 | 6 | 0.972 |
Cerebrovascular disease | 5565 | 19.4 | 5567 | 19.4 | 0.983 |
Ischemic heart disease | 8549 | 29.7 | 8550 | 29.7 | 0.993 |
Follow-up years (median) | 1.23 (0.41–3.68) | 4.75 (2.19–7.89) | < 0.001 | ||